Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy

NCT02966314 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Angioedema

Interventions

DRUG: Omalizumab
DRUG: Placebos

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]